Pricing Log in Create free account

Cellectar Biosciences, Inc. (CLRB) vs Psyence Biomedical Ltd. (PBM)

Cellectar Biosciences, Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. Cellectar Biosciences, Inc. and Psyence Biomedical Ltd. are of similar size ($11.2M and $10.9M). Cellectar Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.1×. Across the 9 metrics below, Psyence Biomedical Ltd. leads on 5 and Cellectar Biosciences, Inc. on 4.

Valuation

Metric CLRB PBM Biotechnology median
P/E n/m 0.13 10.26
P/S n/m n/m 9.18
P/B 0.48 0.06 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.83 1.91 0.65
EV/Sales n/m n/m 8.98
Earnings yield (395.97%) 759.84% (34.89%)
Free cash flow yield (137.75%) (1,147.64%) (24.52%)

Profitability

Metric CLRB PBM Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (125.99%) (23.52%) (50.12%)
Return on assets (88.70%) (6.74%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLRB PBM Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 80.07% (138.35%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLRB PBM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.66 8.09 4.89
Net debt to EBITDA 0.58 1.20 1.01

Dividend

Metric CLRB PBM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLRB PBM Biotechnology median
Market cap 10.87m 11.21m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack